LNSR

Lensar Inc

• PUBT·06/05 21:30

  LENSAR files Form 3 for Interim CFO Michael A. Rossi reporting no securities owned

• TipRanks·06/02 00:26

  Lensar Inc. Earnings Call Balances Recovery And Risk

• TipRanks·05/29 21:03

  LENSAR Appoints Interim CFO, Accelerates Governance Timeline

• Benzinga·05/29 20:09

  Lensar Appoints Michael A. Rossi As Interim CFO Effective May 29, 2026

• PUBT·05/29 20:07

  LENSAR names Michael Rossi interim CFO effective May 29

• Reuters·05/29 20:06

  LENSAR - APPOINTS MICHAEL A. ROSSI AS INTERIM CFO EFFECTIVE MAY 29, 2026 - SEC FILING

• TipRanks·05/11 13:30

  Analysts Conflicted on These Healthcare Names: Treace Medical Concepts (TMCI), NewAmsterdam Pharma Company (NAMS) and LENSAR (LNSR)

• Seeking Alpha·05/08 15:32

  LENSAR signals 2027 as “really, really good” year as it rebuilds distributor orders after Alcon deal termination

• PUBT·05/08 13:59

  LENSAR publishes corporate presentation on ALLY robotic laser cataract surgery system

• Seeking Alpha·05/08 11:21

  LENSAR GAAP EPS of $0.00 misses by $0.18, revenue of $13.4M in-line

• Reuters·05/08 11:15

  LENSAR Q1 revenue falls 5%, hurt by merger uncertainty; recurring revenue rises 9%

• PUBT·05/08 11:02

  LENSAR Q1 FY26 swings to net income of $36.3 million; revenue falls 5% to $13.4 million

• Benzinga·05/08 11:01

  LENSAR Q1 Sales $13.428M Miss $13.450M Estimate

• Reuters·05/08 11:00

  LENSAR® REPORTS FIRST QUARTER 2026 RESULTS AND PROVIDES BUSINESS UPDATE

• Dow Jones·05/08 11:00

  Press Release: LENSAR(R) Reports First Quarter 2026 Results and Provides Business Update